{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T14:29:14Z","timestamp":1781620154437,"version":"3.54.5"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"43","license":[{"start":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T00:00:00Z","timestamp":1603411200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81300094"],"award-info":[{"award-number":["81300094"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Polymyxin B has been used to treat extensively drug-resistant gram-negative bacteria and shown a better antibacterial effect in the clinic at present. Meanwhile, polymyxin B is associated with several adverse effects. However, there is a lack of awareness that polymyxin B can cause rhabdomyolysis. In this study, we firstly report a case of polymyxin B-induced rhabdomyolysis during antiinfection therapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 70-year-old woman suffering from rheumatic heart disease underwent aortic and mitral valve replacement at our institute. Subsequently, she developed bacteremia and pneumonia caused by extensively drug resistance-acinetobacter baumannii. Polymyxin B was administered for 5 days. During treatment, the patient complained of muscle pain and limb weakness, and her serum creatine phosphokinase and myoglobin levels rose.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>The clinical symptoms and laboratory examination confirmed rhabdomyolysis, and polymyxin B-induced rhabdomyolysis was considered.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Intervention:<\/jats:title>\n            <jats:p>We ceased polymyxin B treatment and monitored the patient daily.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>Serum creatine phosphokinase levels returned to normal, myoglobin levels decreased, and muscle pain was significantly alleviated after cessation of polymyxin B. We identified this as a case of polymyxin B-induced rhabdomyolysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>Here, we report the first reported case of rhabdomyolysis induced by polymyxin B administration. The awareness of rare adverse reaction helps ensure the clinical safety of polymyxin B treatment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000022924","type":"journal-article","created":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T01:04:53Z","timestamp":1603501493000},"page":"e22924","source":"Crossref","is-referenced-by-count":6,"title":["Polymyxin B-induced rhabdomyolysis"],"prefix":"10.1097","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9358-8549","authenticated-orcid":false,"given":"Ming","family":"Ni","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, Henan Provincial People's Hospital"},{"name":"Department of Clinical Pharmacy, Fuwai Central China Cardiovascular Hospital, Zhengzhou"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangdong","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Shanghai General Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Shanghai General Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Henan Provincial Chest Hospital, Zhengzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Shanghai General Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Shanghai General Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,10,23]]},"reference":[{"key":"R1-20230916","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1590\/S0080-6234201400002000011","article-title":"Nephrotoxicity of polymyxin B: experimental study in cells and implications for nursing practice","volume":"48","author":"Neiva","year":"2014","journal-title":"Rev Esc Enferm Usp"},{"key":"R2-20230916","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.1128\/AAC.00013-14","article-title":"Serratia marcescens arn, a PhoP-regulated locus necessary for polymyxin B resistance","volume":"58","author":"Lin","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"R3-20230916","doi-asserted-by":"crossref","first-page":"679109","DOI":"10.1155\/2015\/679109","article-title":"Antibacterial mechanisms of polymyxin and bacterial resistance","volume":"2015","author":"Yu","year":"2015","journal-title":"Biomed Res Int"},{"key":"R4-20230916","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.2174\/09298673113209990185","article-title":"The renaissance of polymyxins","volume":"20","author":"Kadar","year":"2013","journal-title":"Curr Med Chem"},{"key":"R5-20230916","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/ja.2014.164","article-title":"In vitro evaluation of ciclopirox as an adjuvant for polymyxin B against gram-negative bacteria","volume":"68","author":"Kim","year":"2015","journal-title":"J Antibiot (Tokyo)"},{"key":"R6-20230916","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1093\/jac\/dkm357","article-title":"Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review","volume":"60","author":"Zavascki","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"R7-20230916","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3121\/cmr.4.2.138","article-title":"The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature","volume":"4","author":"Falagas","year":"2006","journal-title":"Clin Med Res"},{"key":"R8-20230916","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/phar.1493","article-title":"Adverse reactions associated with systemic polymyxin therapy","volume":"35","author":"Justo","year":"2015","journal-title":"Pharmacotherapy"},{"key":"R9-20230916","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1517\/14656560903334185","article-title":"New information about the polymyxin\/colistin class of antibiotics","volume":"10","author":"Molina","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"R10-20230916","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s00134-006-0515-9","article-title":"Colistin and rhabdomyolysis: a causative agent or an innocent bystander?","volume":"33","author":"Evagelopoulou","year":"2007","journal-title":"Intensive Care Med"},{"key":"R11-20230916","doi-asserted-by":"crossref","first-page":"926","DOI":"10.3109\/0886022X.2012.684513","article-title":"Rhabdomyolysis and severe muscle weakness secondary to colistin therapy","volume":"34","author":"Ozkan","year":"2012","journal-title":"Ren Fail"},{"key":"R12-20230916","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1515\/CCLM.2010.151","article-title":"Rhabdomyolysis: historical background, clinical, diagnostic and therapeutic features","volume":"48","author":"Cervellin","year":"2010","journal-title":"Clin Chem Lab Med"},{"key":"R13-20230916","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ejim.2006.09.020","article-title":"The syndrome of rhabdomyolysis: pathophysiology and diagnosis","volume":"18","author":"Giannoglou","year":"2007","journal-title":"Eur J Intern Med"},{"key":"R14-20230916","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/00002281-199305060-00006","article-title":"Mechanisms of rhabdomyolysis","volume":"5","author":"Knochel","year":"1993","journal-title":"Curr Opin Rheumatol"},{"key":"R15-20230916","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2165\/00007256-199112030-00004","article-title":"Mechanisms of exercise-induced muscle fibre injury","volume":"12","author":"Armstrong","year":"1991","journal-title":"Sports Med"},{"key":"R16-20230916","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/PEC.0b013e31816bc7b7","article-title":"Rhabdomyolysis: a review of clinical presentation, etiology, diagnosis, and management","volume":"24","author":"Luck","year":"2008","journal-title":"Pediatr Emerg Care"},{"key":"R17-20230916","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2165\/00044011-200424010-00008","article-title":"Impaired rehabilitation secondary to muscle weakness induced by meropenem","volume":"24","author":"Margolin","year":"2004","journal-title":"Clin Drug Invest"},{"key":"R18-20230916","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00228-003-0688-x","article-title":"A case of rhabdomyolysis with fatal outcome after a treatment with levofloxacin","volume":"59","author":"Petitjeans","year":"2003","journal-title":"Eur J Clin Pharmacol"},{"key":"R19-20230916","doi-asserted-by":"crossref","first-page":"7489","DOI":"10.1128\/AAC.01216-15","article-title":"Cellular uptake and localization of polymyxins in renal tubular cells using rationally designed fluorescent probes","volume":"59","author":"Yun","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"R20-20230916","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1128\/AAC.04869-14","article-title":"Major pathways of polymyxin-induced apoptosis in rat kidney proximal tubular cells","volume":"59","author":"Azad","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"R21-20230916","doi-asserted-by":"crossref","first-page":"e02690","DOI":"10.1128\/AAC.02690-16","article-title":"Potential toxicity of polymyxins in human lung epithelial cells","volume":"61","author":"Ahmed","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"R22-20230916","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1086\/595977","article-title":"Nosocomial outbreak of infection with pan-drug-resistant Acinetobacter baumannii in a tertiary care university hospital","volume":"30","author":"Valencia","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R23-20230916","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/2110-5820-1-14","article-title":"Renal and neurological side effects of colistin in critically ill patients","volume":"1","author":"Spapen","year":"2011","journal-title":"Ann Intensive Care"},{"key":"R24-20230916","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/jac\/dks437","article-title":"Pharmacokinetics of polymyxin B in patients on continuous venovenous haemodialysis","volume":"68","author":"Sandri","year":"2013","journal-title":"J Antimicrob Chemoth"},{"key":"R25-20230916","doi-asserted-by":"crossref","first-page":"e00483-18","DOI":"10.1128\/AAC.00483-18","article-title":"Personalizing polymyxin B dosing using an adaptive feedback control algorithm","volume":"62","author":"Lakota","year":"2018","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000022924","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T03:49:32Z","timestamp":1694836172000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000022924"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2020,10,23]]},"references-count":25,"journal-issue":{"issue":"43","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000022924","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,23]]}}}